Home » Topics » Nephrology, BioWorld Science

Nephrology, BioWorld Science
RSS

CF-602 shows promise for sexual dysfunction in preclinical studies

Jan. 28, 2015

FDA awards orphan drug status to Sparsentan for focal segmental glomerulosclerosis

Jan. 13, 2015

Keryx Biopharmaceuticals launches Auryxia in the U.S.

Dec. 24, 2014

Xiapex receives positive opinion by CHMP for Peyronie's disease

Dec. 23, 2014

Taiho Pharmaceutical patents novel compounds for urinary incontinence

Dec. 16, 2014

Phase II data for sotatercept as treatment of anemia in hemodialysis subjects

Dec. 12, 2014

Researchers present phase III clinical data for ZS-9 as treatment of hyperkalemia

Dec. 2, 2014

Kissei Pharmaceutical discloses new TRPM8 antagonists

Nov. 24, 2014

Studies compare time to ESRD in aHUS patients treated with supportive care or eculizumab

Nov. 24, 2014

Kissei Pharmaceutical submits NDA in Japan for PA-21

Nov. 20, 2014

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability
BioWorld Science
Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....